top of page

GRRMDP
Global Regulatory requirements for Good Manufacturing and Distribution practices in Pharmaceutical /Biopharma industries

Contact
Ms. Prema Desai
Ms. Bharathi Ramesh
Investigators Observations: Jan 2025 to May 2026
List of the Investigators observations from the warning letters issued between January 2025 to May 2026.
The Investigators observations at the locations of different Pharma companies on the theme point are indicated by the text in various colours.
The classification of compilation is based Subparts 21 CFR 211.
bottom of page